Literature DB >> 3535391

Free insulin profiles in insulin-dependent diabetics treated with one or two insulin injections per day.

P O Olsson, H Arnqvist, H von Schenck.   

Abstract

Twenty-four hour profiles of free insulin and blood glucose were determined in 12 healthy controls and 10 insulin-dependent diabetics treated with insulin regimens based on intermediate-acting insulin injected subcutaneously once or twice a day. The diabetics were ambulatory and in a good glycemic control, i.e. without hyperglycemic symptoms or frequent hypoglycemias and with HbA1 less than 9% (reference value 5.9-7.8%). Body weight was normal and median age (32 years) was the same in both groups. Free insulin was determined after polyethylene glycol precipitation of antibody-bound insulin. The controls had a low basal insulin level (median fasting value 3.9 mU/l) and postprandial peaks with a maximum within 30-60 min. There was no rise in plasma free insulin or blood glucose in the early morning hours. The free insulin profiles in the diabetics were highly unphysiological with hyperinsulinemia between the meals and during the night. The highest plasma free insulin value during the 24 hours was reached before lunch (approximately 5-fold compared to normals, p less than 0.01). Postprandially the free insulin concentrations did not reach the peak levels of the normals. After breakfast, blood glucose rose considerably in the diabetics (p less than 0.02 compared to normals) while the rise after lunch and dinner was not higher than in the healthy controls. The difficulties in glycemic control in the diabetic group, i.e. a blood glucose rise after breakfast and hypoglycemias in some patients, could largely be explained by the unphysiological insulin profiles.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535391     DOI: 10.1111/j.0954-6820.1986.tb02741.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  3 in total

1.  Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.

Authors:  T Hedner; D Elmfeldt; H Von Schenck; E Sjögren; U Smith
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

Review 2.  Management of insulin-dependent diabetes mellitus.

Authors:  D M Nathan
Journal:  Drugs       Date:  1992       Impact factor: 9.546

3.  Application of sebomics for the analysis of residual skin surface components to detect potential biomarkers of type-1 diabetes mellitus.

Authors:  Satyajit S Shetage; Matthew J Traynor; Marc B Brown; Thomas M Galliford; Robert P Chilcott
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.